2
Given the potential for participants to misunderstand SG, we will conduct a pilot study (n=2030) using think-aloud methods to refine the presentation and instructions
Microbiol 12 , 997018 (2022)
If GLP-1 treatment is discontinued, metabolic rate typically remains consistent with body weight
The first slide gives you the opportunity to graph three stages of development Most Productive, Diminishing Returns, Negative Returns
Between October 5, 2018, and February 1, 2019, 304 individuals were randomly allocated to receive either semaglutide 2.4 mg (n = 152) or placebo (n = 152), with a high trial completion rate of 92.8% (participants attending the end-of-trial safety visit)